- Home
- COLB vs LEGN Comparison
COLB vs LEGN Comparison
Compare COLB & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLB
- LEGN
- Stock Information
- Founded
- COLB 1993
- LEGN 2014
- Country
- COLB United States
- LEGN United States
- Employees
- COLB N/A
- LEGN N/A
- Industry
- COLB Major Banks
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- COLB Finance
- LEGN Health Care
- Exchange
- COLB Nasdaq
- LEGN Nasdaq
- Market Cap
- COLB 4.9B
- LEGN 5.4B
- IPO Year
- COLB N/A
- LEGN 2020
- Fundamental
- Price
- COLB $24.51
- LEGN $44.03
- Analyst Decision
- COLB Hold
- LEGN Strong Buy
- Analyst Count
- COLB 15
- LEGN 11
- Target Price
- COLB $28.53
- LEGN $74.60
- AVG Volume (30 Days)
- COLB 2.4M
- LEGN 1.6M
- Earning Date
- COLB 07-24-2025
- LEGN 08-08-2025
- Dividend Yield
- COLB 5.91%
- LEGN N/A
- EPS Growth
- COLB 1.90
- LEGN N/A
- EPS
- COLB 2.37
- LEGN N/A
- Revenue
- COLB $1,830,830,000.00
- LEGN $728,303,000.00
- Revenue This Year
- COLB $17.36
- LEGN $65.33
- Revenue Next Year
- COLB $32.62
- LEGN $54.68
- P/E Ratio
- COLB $10.29
- LEGN N/A
- Revenue Growth
- COLB N/A
- LEGN 112.46
- 52 Week Low
- COLB $19.61
- LEGN $27.34
- 52 Week High
- COLB $32.85
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- COLB 52.68
- LEGN 74.04
- Support Level
- COLB $23.45
- LEGN $38.53
- Resistance Level
- COLB $24.72
- LEGN $43.75
- Average True Range (ATR)
- COLB 0.57
- LEGN 1.57
- MACD
- COLB -0.06
- LEGN 0.38
- Stochastic Oscillator
- COLB 40.71
- LEGN 87.82
About COLB Columbia Banking System Inc.
Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.